News Focus
News Focus
Followers 988
Posts 187589
Boards Moderated 5
Alias Born 02/01/2007

Re: 3xBuBu post# 71309

Wednesday, 05/14/2014 12:08:14 PM

Wednesday, May 14, 2014 12:08:14 PM

Post# of 72997
early movers 5-14

ARTX +22% RGDX +15%

#PREMARKET GAINERS

SNPMarketScope ViewsNews 2014-05-14 08:08:04.000 ARTX AROTECH CORPORATION Acquire Media BENZINGA'S TOP #PREMARKET GAINERS Arotech (NASDAQ: ARTX) shares climbed 22.09% to $4.09 in the pre-market trading session after the company reported upbeat Q1 earnings. Arotech reported its quarterly earnings of $0.05 per share on revenue of $22.40 million. Isis Pharmaceuticals (NASDAQ: ISIS) soared 5.62% to $26.50 in the pre-market trading after the company reported positive Phase 2 data on ISIS-GCGR Rx in HbA1c in patients with type 2 diabetes. Canadian Solar (NASDAQ: CSIQ) shares jumped 2.56% to $28 in pre-market trading as Coca the company announced a partnership with IKEA Australia to build 3.6MW solar systems. MannKind (NASDAQ: MNKD) shares gained 2.43% to $6.74 in pre-market trading after Piper Jaffray upgraded the stock from Underweight to Neutral.. 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Acquire Media |US;ARTX |3260 |US |48398.
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy selection, today announced execution of a commercial agreement with DxM Diagnostico Molecular ("DIFRA"), a leading distributor for cancer testing in Mexico, to offer the ResponseDX testing services to patients throughout Mexico.

All material posted by langlui is purely my opinion and is not buy or sell recommendations. Do your DD, buy and sell based on that DD.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today